by Jordana Choucair | Jan 20, 2022 | D.C. News
President Joe Biden said Democrats will likely have to break up their roughly $2 trillion social spending bill, which includes multiple health care provisions, in order to get it through Congress. Biden also defended his COVID-19 response, saying that his...
by Jordana Choucair | Jan 20, 2022 | Mental Health
Third Horizon Strategies’ latest blog highlights Tym Rourke’s and Sara Howe’s predictions regarding how payers, states, and communities will continue to shift resources to better address health equity and social determinants of health. “The pandemic...
by Jordana Choucair | Jan 20, 2022 | Life Sciences
A new analysis by the Congressional Budget Office found that savings from generics have driven average prescription prices down in Medicare and Medicaid. Between 2018 and 2019, the average price for a generic prescription fell in both program while the use jumped from...
by Jordana Choucair | Jan 20, 2022 | Life Sciences
A group of 27 generic drugmakers agreed to manufacture Merck & Co.’s COVID-19 antiviral pill in an effort to supply more than 100 lower-income countries with the treatment. According to the United Nations-backed Medicines Patent Pool, the drug should be...
by Jordana Choucair | Jan 20, 2022 | Life Sciences
Two Democratic Senators called on the Federal Trade Commission (FTC) to investigate reports of “price gouging and scams” tied to at-home COVID-19 tests. In a letter to FTC Chair Lina Khan, Senators Ed Markey and Richard Blumenthal said that the agency...
by Jordana Choucair | Jan 20, 2022 | Payers
UnitedHealth Group Inc.’s profits surged in the fourth quarter, surpassing its initial 2021 revenue and profit projections. The company’s net income reached $4.07 billion in Q4 2021, up from $2.21 billion the year before. The surge was driven by increased...
Recent Comments